Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NDUFB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SULF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BANK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC44A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
GOLIM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MFSD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DRAM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EAF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SKIL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD58 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C19orf24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PBXIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MBNL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C12orf73 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on